Trial · NCT00563706
Participant flow54
How many started, completed or left each group, period by period.
1 to 20 of 54
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Placebo | 37 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 50 mg | 18 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 100 mg | 8 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 150 mg | 19 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 200 mg | 16 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 300 mg | 19 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 400 mg | 12 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Vabicaserin 600 mg | 30 | |
| DB Treatment Period (Day 1 up to Day 28) | STARTED | Risperidone | 43 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Placebo | 20 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 50 mg | 13 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 100 mg | 3 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 150 mg | 9 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 200 mg | 11 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 300 mg | 14 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 400 mg | 9 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Vabicaserin 600 mg | 16 | |
| DB Treatment Period (Day 1 up to Day 28) | COMPLETED | Risperidone | 32 | |
| DB Treatment Period (Day 1 up to Day 28) | NOT COMPLETED | Placebo | 17 | |
| DB Treatment Period (Day 1 up to Day 28) | NOT COMPLETED | Vabicaserin 50 mg | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00563706/flow